Stoke Therapeutics, Inc.: late-stage zorevunersen for SCN1A Dravet Syndrome with durable 3-year data, Phase 3 EMPEROR and ...
The order comes amid concerns over potential misuse of large motorcycle rallies or processions that could influence voters or disrupt the electoral process in the sensitive phase covering multiple ...
Abandon the “one-size-fits-all” approach in favor of balancing motor sizing, energy loss, and operational cost factors to ...
BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it will host ...
Russia is increasing use of the Molniya-2 drone for strike and reconnaissance missions due to its ability to evade Ukraine's ...
EV powertrain firm Tsuyo secured two patents for high-efficiency, fault-tolerant motor technologies. These Design-in-India ...
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, today announced the U.K.
A federal law meant to go into effect in 2027 will require automakers to install technology aimed at preventing drunken ...
Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, ...
TVS Ntorq 150 goes racing as this sporty big displacement scooter has been homologated with FMSCI for motorsport events in ...
French carmaker Renault no longer sells its brand in the Chinese market, but it's not afraid to design and develop them there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results